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ABSTRACT 
An investigation was made  to  determine  the  effect 
of the  natural   estrogen estrone,   in varying concentrations 
and over varying periods  of  time,   on  the   chromosomes  of 
human female peripheral  blood lymphocytes   in vitro. 
All  experiments  were   carried out according to  a modifica- 
tion of  Tips'  Micro Procedure  for Peripheral  Leucocyte 
Culture.     One   set  of leucocyte   cultures  was  exposed  to 
6.0 ^~g of estrone   for  24,   48  and 12 hours,   and another 
set  of  cultures  was  exposed  to   0.6 ^-g of  the  hormone 
for  the   same  respective  time  periods.     Chromosome   rpreads 
obtained from each  culture   were  analyzed in  respect  to 
control   groups   for  changes   in morphology and mitotic rate. 
100  control  and  50  estrogen-treated spreads  were  analyzed 
for each experimental   group  in  consideration of morphology, 
and  500  control   and   500  estrogen-treated spreads  were 
analyzed for each group  in  conrideration of mitotic  rate. 
The  net  effect  of estrone  at 0.6 ^g is  an  increase   in 
mitotic  rate  in  the  48  to  72 hour range   and an increase 
in polynloidy in  the   24  to   48 hour range,   with the  peak 
of activity at  48  hours.     At  6.0 y"-g the  net  effect  is 
a  decrease   in mitotic  rate  and an  increase   in polyploidy 
in the   24   to  48  hour range,   the  peak of activity coming, 
again,   at  48 hours.     Marked  endoreduplication  occurs  at 
■ 
48  hours  with 6.0 ^~g of estrone. 
Numerous  implications  may be  drawn  from such effects? 
as  estrogen hap   been  shown  to  elicit  in  this   investigation. 
From the   current  literature   three  areas  suggest possible 
immediate  applications   for  the   conc3txsions  drawn here: 
1) "Target"-"non-target"   tissues:     A  need  to 
re-examine   these   concepts  is  indicated by 
the  marked response   to   estrogen exhibitted 
by lymphocytes. 
2) Embryonic  differentiation:     The  varying effect 
of estrogen  over  varying periods of  time 
suggests  a  direct  relation   to  embryonic 
differentiation,   where   time   is  a key factor 
in  the   control  of  tissue  response  and 
developmental  direction. 
3) Cancer research and diagnosis: The link which 
estrogen has been shown to have with cancerous 
changes  in  the  human and in animals  suggests 
a possible  application  of  cytogenetic  evidence 
of  estrogen action  to   diagnostic and research 
techniques  in  the  area  of malignant  trans- 
formati on. 
INTRODUCTION 
The  natural  estrogens  are   hormones  secreted  in the 
human  female  by  the ovaries,   the   Graafian  follicles,   the 
corpus  luteura and,   during  pregnancy,   the  placenta,   under 
the  influence of FSH  from the  pituitary.     In  the  normal 
female  the  estrogens   bring about   changes  in the  vaginal 
epithelium and  prepare the uterus   for  reception  of the 
fertilized ovum.     Estrogens   stimulate  growth  of the  mam- 
mary glands and affect development  of secondary  sex char- 
acteristics.     The  natural  interaction  of all the   gonadal 
and gonadotropic  hormones  in the  human   (male   or  female)   is, 
however,   an   extremely  complex  process,   and   it   is   difficult 
to define  these various  physiological  events  as specific 
effects of  the hormone estrogen alone.    They involve, 
rather,  the  intricate   interaction  of  estrogens,   progestin 
and  the   hormones  of  the  pituitary.     It  has  been,   therefore, 
the effort  of  research to attempt   to  determine   the  effects 
of estrogen   on  a more  specific  level.     Investigations   have 
been made  to discover not   only  its general influence  in 
normal  development,   but  its  effect on  individual  tissues, 
cells  and  their  components as well,  and  to determine   the 
exact  mechanism  by which  such   effects  are  accomplished. 
Certain  "target tissues,"  tissues which  respond 
dramatically and  characteristically to  the  presence of 
estrogen, have been the subject of many investigations. 
Recent studies on the cornification of vaginal epithelium 
and additional responses of the vagina to estrogen stimu- 
lation have been conducted by Kusuda (1963) and Hermreck 
(1966).  Uterine response to estrogen (stroraal edema, 
vasodilation, gland proliferation) has been well docu- 
mented.  Current investigation (Nillson, 1966) concerns 
additional factors such as the increased adhesiveness of 
uterine epithelium as a result of estrogen treatment. 
Other target tissues, including the oviduct, mammary gland 
and pituitary, have also been studied in detail (Kim, 1963; 
Cutts, 1964; Schitkova, 1964; Harris, 1965). 
Many tissues designated "non-target," however, 
have been shown to demonstrate pronounced responses to 
estrogen. Desoille (1961) reported significant leukopenia 
and a decrease in red blood cells in both male and female 
rabbits subjected to estrogen treatment. Estrogen has 
been found to raise the level of certain serum proteins in 
sheep (Slebodzinski, 1962) and some plasma proteins in man 
(Musa, 1965).  Jarzyna (1966) found that estrogen adminis- 
tration impaired blood clotting in rabbits, and Bennett 
(1966) reported a reduction in antiplasmin and fibrinogen 
levels as a result of estrogen treatment in the human. 
Injection of estrogen has been found to produce an increase 
in thyroid weight and thyroidal radioiodine uptake in the 
rat (Boccabella, 1964; Yamada, 1966). Fisher (1963) 
reported evidence of direct stimulation of pituitary TSH 
release by estradiol benzoate.     Estrogen has been  found to 
affect mast  cells of the  rat uterus   (Levier,   1965)  and L 
strain fibroblasts in tissue  culture   (Kuchler).    In "The 
Action of  Hormones  on  Cell and Organ Cultures"  Use Las- 
nitzki gives a review of varied and  conflicting reports of 
estrogen-responsive  tissue  from previous years:     dental 
pulp,   bone marrow and spleen from rabbits  (Yagl ,   1940); 
chick iris epithelium (Kubo,   1933,   1939);  mouse heart 
fibroblasts   (Von Haam,  1940)  and chicken heart  fibroblasts 
(Tageguti,  1937); mouse ear epidermis  (Bullough,  1954a). 
Estrogen thus displays a pronounced and unmistakable 
influence on a wide range  of both "target" and "ncn-target" 
tissues.    Many attempts have been made to  explain    the 
varying results  of estrogen activity in the elucidation 
of such widely differing responses as have been  outlined 
here.     A review of the literature will show that consid- 
erations of possible mechanisms of estrogen action have 
followed three major lines of thought.     These areas of 
thought place the effect of  estrogen at three  different 
levels of activity: 
1) Effect on the cell membrane level:     effect on 
metabolism by altering membrane  permeability, thus 
making substrate and cofactors more available. 
2) Effect on the intracellular,   cytoplasmic  level: 
a)    altering of the rate of enzyme production 
b) Regulating  the   rate  at  whi ch  useful  energy is 
made available to the  cell 
c) altering activity of a preformed protein mole- 
cule  (converting an inactive protein to one 
with enzymatic activity) 
d) competing with one  of  the cofactors for a site 
on an  enzyme molecule,   thus  depressing  the 
over-all activity  of  the   system 
e) being involved itself as a coenzyme or cosub- 
strate in the enzyme system 
3)     Effect on the nuclear level:     involvement in the 
biosynthetic process of nucleic acid synthesis. 
Experimental evidence at the  present time   seems to indicate 
that the  mechanism  is  actually in agreement with the  third 
line of thought,  that of an effect on the molecular level. 
Gorski   (1964)   reported  that the   synthesis   of  rapidly labeled 
RNA in the rat uterus,  measured by in vivo cytidine—H3 
incorporation  into   RNA,   was increased  by 86% within  one 
hour after estrogen administration.     He  concluded  that  the 
synthesis of all RNA types is affected,  probably by an 
increase in the activity of RNA polymerase.    Man sour  (1965) 
also  proposed that the  hormone  might  act  directly on the 
genome  by elucidating DNA-primed RNA biosynthesis,  the RNA 
then pervading tissue  cells and producing  structural and 
enzymatic alterations.    Bonner  (1965)   stated that estrogen 
produces its effects by eliciting the  synthesis  of RNA, 
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which then elicits the  synthesis of proteins,   in the  form 
of key enzymes,  and Hechter (1965)   proposed the  "hormone- 
gene" thesis,  which states that "hormones produce effects 
by regulating genetic programming expressed in terms of 
enzyme formation and consequent change  in cellular metab- 
olism."    Segal  (1966)   supported the  RNA-based concept  of 
estrogen action by a series of experiments in which 
estrogen action was  shown to  be  inhibited  by  known inhib- 
itors of RNA synthesis, and estrogen effects were  shown to 
be produced by estrogen-activated biologically active RNA. 
The  present  state   of opinion     concerning     the 
mechanism of action of   estrogen  might,   in one   sense,   make 
a cytogenetic  study in this area unfeasible.     RNA syn- 
thesis in most  cells is at a peak during the interphase of 
mitosis,   while  cytogenetic  study  of the  human  is   generally 
confined,  at this time,   to the metaphase chromosomes.    In 
another sense,  however,  a  study of the effect of  estrogen 
on chromosomal morphology and raitotic rate  is very appli- 
cable   to the   problem of mechanism.     Although present theory 
ascribes  estrogen action  to  enzyme  regulation  through 
RNA-synthesis,   the  influence of estrogen on  different, 
"non-target" tissues has not been resolved,  nor has the 
problem of differential  estrogen effects over    varying 
concentrations and   periods  of exposure  to the hormone.     It 
is therefore important to  determine  any visible   effects 
which estrogen might  have  on the actual genetic material of 
a non-target  tissue,   such as the  blood lymphocyte.    Visible 
effects,   detectable   in a   cytogenetic  study,  might   include 
such factors  as variations   in   chromosome   morphology   (heter- 
ochroraatin,   premature   separation of  chromatids,   coiling, 
breaks,   individual   chromosome   changes);   variations  in 
chromosome  number   (aneuploidy,   polyploidy,   endoredupli- 
cation);   or  changes in mitotic  rate.     Whether   such   effects 
could   be   correlated with  the  action  of  estrogen  in  RNA 
synthesis,  or whether they might  simply act as specific 
arai   characteristic  evidences  of estrogen   action  in the 
cell,   they  could   be  of  great  value  in  both  theoretical and 
practical  application. 
Thus,   the   present   investigation  was designed  to 
determine   the   effects  of   estrogen,   in  varying     concen- 
trations  and  over varying   lengths  of  time,   on   the   chromo- 
somes  of  a  "non-target"  tissue,   human  female   peripheral 
blood   lymphocytes.     An attempt   was made to  consider all of 
the  cytogenetic  factors  previously outlined as  possible 
visible  effects.     It  does not  appear  from the   literature 
that  such a  study has been   conducted  before  this time, 
and  it  would   seem  that  this   investigation  is  not  only 
valuable,   but   very necessary  to   the  understanding  of 
certain  concepts  related to  estrogen  activity     and the 
mechanism by which  this  activity  is  governed. 
MATERIALS AND METHODS 
A 3tudy of the effects of estrogen on the chromo- 
somes of human female peripheral blood leucocytes was 
conducted through analysis of lymphocyte chromosomes after 
in vitro exposure to varying dilutions of estrogen over 
varying periods of time. Estrogens are produced in 
several forms.  Of the three principle naturally secreted 
estrogens the form employed in the present study was 
estrone.  This form is converted, in the body, to the 
other forms by the following scheme: 
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Estrone is intermediate between the other two forms in 
biological strength, its activity being 100 times that of 
estriol and 1/12 that of estradiol. 
All experiments were carried out according to a 
modification of Tips' Micro Procedure for Peripheral 
Leucocyte Culture, which may be outlined as follows: 
1) Preparation of cultures:  3-4 drops of blood 
obtained by sterile technique and placed in a 
^ 
vial containing  culture medium (preparation of 
culture medium is  listed on  page 11) 
2) Incubation:     36.5°-37°C for four days 
3) Harvesting of leucocytes: 
a) Colchicine  treatment:     0.02  cc  of   colchicine 
solution   (100/Mg/ral)  added to each  culture, 
cultures incubated 3-5 hours longer:    to arrest 
mitosis  at raetaphase 
b) Treatment with  balanced  salt  solution: 
8-10 ml added,   followed by  centrifugation:     to 
remove medium  components 
c) Hypotonic  treatment:     cells   resuspended in 
2.0 ml distilled water,   allowed to   stand 8-10 
minutes,   recentrifuged:     to disperse chromo- 
somes  from cell nuclei 
d) Fixation:     1:3 glacial acetic acid—absolute 
raethanol solution 
4) Preparation and   staining  of   slides   (staining 
procedure  given on   page 11) 
Cultures  were   submitted to   experimental  treatment   during 
the   four-day  incubation  period.     One   set of  cultures,   I, 
II and III, were  exposed to 6.0 -*<g of estrone for 24,  48 
and 72 hours,   respectively.     Another set,  IV,  V and VI, 
were   exposed  to  0.6 Mg of   estrone  for the   same   respective 
time lengths.    A control, untreated with estrone, was run 
with each  experimental  culture.     Such factors as the day 
of  the  subject's menstrual cycle   and any  occurence  of  ill- 
ness,   unusual  stress or  medication,   which  might  affect 
experimental   results,   were  noted.     Normal  levels   of   estrogen 
in the human female  range  from 0.1 to 0,3 Mg/l,  with sub- 
stantially higher values  (up to 1 Mg/l) only in the middle 
third of the cycle   (Svendson,  1964).     Thus,  it was  impor- 
tant   to note  the day  of the   subject's  cycle   in order to 
determine  whether high  levels   of  the  hormone  might  be 
present.     It was,   of  course,   necessary to   take   into account 
such  factors  as  steroid  medication,   illness  or   stress, 
which  might   have  affected the   normal   hormone   levels.     Had 
any  of  the   subjects   recently  had X-rays taken  this  too 
would   have  been noted,   since  chromosome  breakage   often 
results  from exposure  to  X-rays. 
After harvesting   of   cultures  and   preparation  of 
slides a detailed chromosome analysis was conducted for 
each control and  experimental group.     The  analysis  included 
a  count of  mitotic  index,   determination of  chromosome 
number and  a  study  of  morphology,   considering   chromosome 
breaks,   heterochromatic   regions,   premature   separation of 
chromatids,   appearance of   rosettes,   degree   of   coiling,   and 
any other morphological  variations.     Each  experimental 
culture  was  analyzed  in  relation to  its  own   control,  and 
care  was taken  to make  uniform  studies  of all  experimental 
groups.     For morphological  analysis   100 counts were  made 
for each  control group and   50  counts  for  each  of the   six 
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estrone-treated groups.     Data on the mitotic index for  each 
group was   obtained by  taking  a   count  of  the  number of 
mitotic  figures  per 500  cells,   for both  control and   experi- 
mental groups. 
Photographs  were  made  and  karyograms   prepared 
(according  to   standards   established  by the  Chicago  Confer- 
ence on  Standardization  in  Human  Cytogenetics, December, 1966) 
for further study of individual chromosome  spreads. 
Care  was  taken  throughout   this   investigation  to 
standardize procedure,   and  methods were   particularly de- 
signed  to   eliminate   variables as much as  possible.     Careful 
sterile  technique was,   of   course,   used throughout   the 
investigation.     Strict uniformity  was  maintained in  regard 
to  timing.     Wherever a  range of   effective  times was  sug- 
gested  in  the   original  procedure,   for  example,   an   exact 
and consistant time  was used here.    Uniformity of  culture 
medium was  preserved.     The   colchicine  and  phytohemagglu- 
tinin used in this investigation were  standardized    in 
relation to  each  other,   in  order to  eliminate   technical 
error.     Slides were made  immediately after harvesting  of 
leucocytes in each  case,   to eliminate error which might have 
arisen from  letting the   cultures  stand  overnight  first   (a 
possible  variation of this  procedure).     In the   final analysis 
of the   chromosomes  care  was taken to  consider  a  large  number 
of spreads and   to make   a  large  number of  counts  in  order to 
assure mathematical significance to  the  data. 
Culture Medium 
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Culture Medium #199 with NaHC03 
Fetal Bovine Serum 
Heparin - lOOOU/ml solution 
Penicillin-Streptomycin mixture 
Phytohemagglutinin 
4 ml 
1 ml 
0.1 ml 
0.1 ml 
0.1 ml 
Procedure  for  Giemsa Stain 
Giemsa: 90 ml distilled H20 
7 ml Giemsa stain 
5 ml  0.15 M    NH^OH 
1)1N    HC1     (60°C) 
2) Distilled H20 
3) Giemsa 
4) Acetone I 
$) Acetone II 
6) Acetone/Xylol 
(50:50) 
7) Xylol I 
8) Xylol II 
9) Mount 
10 min 
rinse 
8-15 min 
rinse 
rinse 
2 rain 
5 min to hrs 
10 min  to   hrs 
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RESULTS 
A summary of observations  and  experimental  results 
for the  investigation,  as  outlined  in MATERIALS AND METHODS. 
is given  in  tables and graphs   in the  following  pages. 
Table   1,   page   13,  gives an  analysis  of  chromosome 
number and morphology after 6.0 Mg estrone treatment at 
24,  4$ and 72 hours. 
Table  2,  page 14,  gives an analysis of  chromosome 
number and morphology after 0.6 Mg  estrone  treatment  at 
24,  43 and 72 hours. 
Table  3,  page 15,  gives a summary of  data  concerning 
mitotic  index for all  experimental  groups. 
Figure  1,   page   16,   illustrates  percent  polyploidy 
versus  length of  exposure to estrone at 0.6 Mg. 
Figure  2,   page   17,   illustrates  percent   polyploidy 
versus  length of  exposure to estrone at 6.0Ag. 
Figure 3,   page   18  summarizes mitotic  index as a 
function  of  time   of  exposure to   estrone  for both  estrone 
concentrations. 
Photocopies  of photographs  and karyotypes  illustra- 
tive  of  controls  and  of estrogen effect  in the  various 
experimental   groups will  be   found at the   end   of  the text 
of this  paper.     The  originals  for these photocopies are 
on  file  in the  office of  the  Biology Department,  UNC-G. 
Table  1.     Chromosome  Number and Morphology at  6.0 Mg 
Culture  Uumber 
I II III 
Con,   Est„       Con    Est       Con    Est 
13 
odal 
Number  (46) 
'/o I-onmodal 
Kumber 
(other  than 
Polyploid) 
°/o Polyploid 
i° Partial  or 
Total 
Endoreduplication 
87       58 87       56        84      82 
12       34 
8 
12       32        15      18 
1 
0 
18 
10 
1 
0 
0 
0 
Rosettes 8 8 12 
i» Coiling 20 
$> Heterochromatin       0 0 
arly  Separation    1 6 
of  Chromatids 
fa Chromosome 
#1 Aberrations 
0 
Con =  Control 
"Est = Estrone 
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Table   2.     Chromosome  Number and Iv.orpholofly at 0.6 MR 
IV 
Culture  Number 
V VI 
Con,   Estr ,         Con    Bet Con    Est 
°/o Modal 
Number   (46) 90 72 90      80 82       70 
■/> Nonmodal 
Number 
(other  than 
Polyploid) 
9 18 9         6 18       28 
fo Polyploid 1 10 1         14 0         2 
Jo Partial  or 
Total 
Endoreduplication 
0 0 0         0 0         0 
r/o Rosettes 11 4 11       8 5         16 
•/- Coiling 0 4 0        18 4         6 
fo Hcterochromatin 0 0 0 
'arly  Separation       0 2 
of Chromatids 
>° Chromosome 
#1 Aberrations 
8 
Con =  Control 
"Est = Estrone 
Table   3«     Summary of  Data  on Mitotic  Index 
15 
6.0 Mg 
Day of 
Cycle 
Length of 
ixposure 
Llitotic  Index 
of Control   (MQ^ 
Mitotie  Index 
of Experimental   (M„) 
A Mitotic  Index  (AM) 
=     (KE-V 
Culture  Number 
I II III 
30 
0.070 
0.070 
0.000 
30 
0.070 
22 
24 hrs 48 hrs 72 hrs 
0.081 
0.080 0.067 
0.010 -0.014 
Q,6^g 
Day of 
Cycle 
Length  of 
Exposure 
Mitotic  Index 
of Control   (MQ) 
"iitotic  Index 
of  Experimental   (M.,) 
AMitotic  Index  (AM) 
Culture  Number 
IV V VI 
26 
0.057 
0.062 
0.005 
26 
0.057 
0.093 
0.036 
8 
24 hrs 48 hrs 72 hrs 
0.075 
0.109 
0.034 
1    Mitotic  Index     (Based on  500   counts per culture) 
is  calculated as     number mitotic  figures 
number non-mi totic   cells 
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\    POIVPIOIDV 
15 
7m POLYHOIDV 
Wm      TIME    Of    EXPOSURE    TO    ISTtOMI 
• •Am 
10 
5 
l • 
I 
24 48 72 
LENGTH    OF   EXPOSURE     (krt.) 
Fl garm   1. 
COMTtOL 
ESTtONI 
X    POIYHOIOY 
15 
10 
CONTROL 
ESTROHI 
17 
I 
I 
1 
24 48 
LENGTH      OF     EXPOSURE 
72 
( hrs.) 
I 
Figur*   2. 
X     POIYPLOIDY     »•     TIMl    Of     EXPOSUIE    TO    ISTtQMf * -* 
18 
Zk      MITOTIC INDEX 
0   030 
0 0 20 
0 010 
-0 010 
TIME 
24 
Pl««ro   3. 
A    MJTOTIC INDEX       »•       TIME       Of      ISTftONl       IXPOSUftl 
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DISCUSSION 
It  can  be   clearly  seen   from  the   data  in   Tables  1, 
2 and 3,  and from Figures 1,  2 and 3,  that  estrogen  has a 
significant effect on the  chromosomes  of  female peripheral 
blood  lymphocytes.     A great  increase  in nonmodal numbers 
of chromosomes,  and a great  increase  in amount   of  coiling, 
can be seen in some  instances  (Tables 1 and 2),   but  such 
effects are,   on  the  whole,   inconsistent.     The  most   striking 
effects,  rather,   seem to be  the increase in polyploidy 
(Tables  1  and   2),   which  follows  an  interesting   pattern 
with a  sharp peak in the  4# hour range   (Figures  1 and 2), 
and the   change   in  mitotic  index  (Table   3),   which  gives  a 
striking pattern as graphed in Figure   3.    Sandberg (1966) 
reports that the  normal level of  polyploidy in a lympho- 
cyte culture may range from 0.7 to  2.0 polyploids  (based 
on a count  of  250 cells).    The  level of polyploidy seen in 
the  present  study thus reaches a significant  percentage 
when related to  Sandberg's results and to the  control 
groups of this experiment  itself, and  it  is important  to 
note   that  this   effect is   seen  at   estrogen  concentrations 
only  slightly  higher than  physiological  concentration.     The 
effect  of  estrogen  on mitotic  index is  also dramatic   at 
these concentrations,  particularly in the 48 to  72 hour 
range.     From Figure 3  it  may be seen  that   estrone  at 
0.6Mg gives a small increase in mitotic index at 24 hours 
and greater increases at 48 and 72 hours.     The     effect at 
T 
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6.0^<g is no change at 24 hours,  a  small increase at 48 
hours and a large decrease at 72 hours.     It would  seem 
likely,  then,  that the net effect of   estrone at 0.6^-g is 
an increase in mitotic  rate  in the 46 to 72 hour range and 
an increase in polyploidy in the  24 to 46 hour  range, with 
the peak of activity at 48 hours.    At 6.0 xg the net effect 
is a decrease in raitotic rate   (with a small increase at 
48 hours)  and an increase in polyploidy in the  24 to 48 
hour range,   the peak of activity coming,  again at 48 hours. 
The  occurence of marked endoreduplication at  48 hours with 
6.0^-g of estrone  suggests a particularly strong,   perhaps 
toxic,   effect at this level. 
Numerous implications may be  drawn from     such 
effects as estrogen has been shown to elicit here.     The 
involvement  of  hormones   in  embryonic  differentiation,   for 
example,  makes an  understanding  of hormone  action  over 
varying periods of time necessary.    Watterson   (1959),  at 
the Symposium on  Endocrines  in Development,   emphasized  the 
importance of repeated hormone action over a period of 
time,   due  to the   changing  capacity of embryonic  material 
to  respond:     "the agent   [hormone!    involved more   likely 
operates at different times,   repeatedly,   producing different 
results,   depending  on the time at which it  works.     It  is 
absurd,   therefore,   to  inquire  whether  a  particular response 
is determined hormonally  or ganetically.     Even  if it ap- 
pears  superficially  to  be  determined hormonally,     the 
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hormone  source is determined by the  genome  plus  the  embry- 
onic history that is behind   it when the   product  is  first 
encountered."    The  problem of hormone  action in  embryonic 
development   is  thus   a  complex relation  between   embryonic 
history and the  nature of a hormone  action over given 
periods of time. 
The   effects which  estrogen has  been   shown to   elicit 
in  cultured  lymphocytes  must  also  reflect on the  concept  of 
the  "target  tissue."    The  marked  response  shown   by  chromo- 
somes  of a   "non-target tissue" in this   study suggests that 
further cytogenetic  studies should  be  conducted on other 
non-target areas.    A determination of the  chromosomal 
response pattern in these tissues would   be invaluable both 
for the  elucidation  of the general mechanism of  action of 
the  hormone  and  for medical applications.     Steroid  treat- 
ment   is  a  common medical  technique at the   present time. 
The   synthetic  progesterone-estrogen  contraceptive  is   being 
used  secondarily for many problems  ranging from   stimulation 
of  conception to   regulation  of the  menstrual  cycle. 
(Maisel,  1965),     In  such clinical use of the  steroids, 
effects  on  the  target organs   are   considered  carefully. 
What,  nowever,   could be  the long-range  effects on non- 
target  tissues,  which are   not   considered?     What   effect 
might  estrogen treatment   have,   for example,   on the   blood 
protein  level  or the  lymphocytes?     What  effect  on the  cells 
of the   heart?     A  study of   specific,   visible   chromosomal 
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response to the hormone estrogen in various tissues might 
make it possible to detect tissue response as a result of 
clinical hormone treatment. 
A  final  example   of application of the  present   study 
may be   seen  in the   frequent   documentation of   estrogen 
effects on cancer cells or in the  stimulation of  cancer- 
ous changes.     In 1933 Cook wrote  "cell proliferation 
which characterizes the oestrous   state is in  some  respects 
reminiscent of the   early stages of malignant growth"  (as 
quoted by Sobotka,   1938).     Later Sobotka  (1938)   stated the 
possibility that  biodehydrogenation of sterols or bile 
acids might  be   the   physiological  method  for the   production 
of the   sex hormones,  and   that   further dehydrogenation by a 
faulty mechanism might   give   rise to  tumor  stimulating  sub- 
stances.     Since then many  researchers  have  documented 
relationships  between  estrogen and   carcinogenic   effects. 
Kim   (1966)   reported   stimulation of  mammary tumors as a 
result  of  estrogen   treatment   in the   rat.     Cutts  had 
reported similar effects in 1964,  while  Lagova  (1964) 
gave  evidence   for inhibition  of  mammary  cancer in the  rat 
by thioTEPA and   estrogen.     Zuraoff   (1966)   reported a 
relationship  between  bi©transformation  of  estrogens and 
breast   cancer in   the  human.     Relationships  have  been   shown 
between  estrogen  and  liver  cancer in the   rat   (Science, 
1966),   uterine   cancer  in  mice   (Min-Hsin,   1964),   and  some 
forms of human   cancer    (Rauramo,  1963;    Daly,     1963; 
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Timonen,   1963).     Lancet   (1966)  reports the   study of the 
relation  between  the  endocrine   system and  some  human   cancers 
as one   of  the  two major  areas of   cancer  research today. 
Here,   then,   might  be  one   of  the  major  applications  of a 
relation between estrogen and  cyto gene tic  studies.     The 
establishment  of  estrogen   effects  in the   present  study 
could  be related to   cellular changes in cancerous  tissue. 
A  record  of  the   effects  of   estrogen   on the   chromosomes  of 
non-cancerous  or  pre-cancerous   cells  might  be   developed 
into a valuable   research or diagnostic technique to  be 
used in the detection of  early cancers and  the  study of 
the  actual mechanism of  malignant   transformation. 
Thus,   it  can be  seen   that the   practical and  theo- 
retical  implications of   the   present   study are  varied and 
far-reaching.     This  is,  in a sense,  a  pilot   study,  since 
it  suggests many possibilities for  future investigation 
in the  area of hormonal effects described by cytogenetic 
evidence.     The   range   for  such  future   studies   is,   indeed, 
unlimited,   since application  could   be  made  to  an  infinite 
range  of tissues,  using  a wide variety   of hormones.     The 
scope  of such studies could thus  be  made to   encompass many 
fields  of  investigation,  and  the  value   to   scientific know- 
ledge,   both  theoretical and applied,   could   be   immeasurable. 
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